AITX Reports Q1 FY2027 Results: Total Revenue of $1.83 Million; Revenue Excluding Largest Customer Up 52%; Operating Loss and Cash Use Narrow

Losses are widening, cash is tight, and future growth is mostly unproven promises.

What the company is saying

Artificial Intelligence Technology Solutions, Inc. (OTC:AITX) is positioning its Q1 FY2027 as a pivotal period, describing it as a 'foundational commercialization quarter' where key investments and initiatives are expected to drive future growth. The company wants investors to believe that operational improvements and product advancements—particularly with SARA™ and ROAMEO™—are setting the stage for meaningful revenue expansion in the coming quarters. Management highlights a 52% year-over-year and 16% sequential increase in revenue from customers other than its largest client, framing this as evidence of successful diversification and market traction. The announcement emphasizes the transition of SARA™ from development to commercial activation, the initial commercial deployment of ROAMEO™ units, and the consolidation of residential initiatives into enterprise-focused efforts. It also spotlights a $100,000 monthly revenue backlog from signed SARA contracts as a future growth lever, though it is careful to note that realization of this backlog is not assured. The tone is measured but optimistic, with management projecting confidence in near-term revenue growth and the possibility of achieving at least one month of positive operating cash flow during calendar 2026. CEO, CTO, and founder Steve Reinharz is the only notable individual identified, and his deep involvement signals founder-led continuity but does not introduce external validation or institutional credibility. The communication style is factual but leans on forward-looking statements and aspirational language, fitting a strategy aimed at reassuring investors that operational progress will soon translate into financial improvement.

What the data suggests

The disclosed numbers paint a challenging financial picture. Total revenue for Q1 FY2027 was $1,831,202, down about 1% year over year and 8% sequentially, indicating that overall top-line growth is stagnant or declining. While revenue from customers other than the largest client grew 52% year over year to $1,463,319, this was offset by a sharp 59% year-over-year and 50% sequential decline in revenue from the largest customer, which now contributes only $367,883. Gross profit for the quarter was $1,183,824, with a gross margin of 65%, slightly down from 67% a year ago. Operating expenses fell 12% to $3,893,188, and loss from operations narrowed by 15% to $2,709,364, showing some operational discipline. However, net loss increased 24% to $5,715,838, driven by $3.0 million in non-operating costs, compared to $1.4 million in the prior year. Cash and cash equivalents at quarter-end were just $94,643, and while net cash used in operating activities improved by 17% to $2,759,307, the company remains deeply cash flow negative. The weighted average share count more than doubled to 326 million, suggesting significant dilution. No audited financials, full balance sheet, or detailed segment breakdowns are provided, limiting transparency. An independent analyst would conclude that, despite some operational improvements, the company’s financial trajectory is deteriorating: losses are growing, cash is nearly depleted, and the business is not yet demonstrating sustainable growth or profitability.

Analysis

The announcement presents a balanced mix of realised financial results and forward-looking statements. While the company discloses detailed revenue, gross profit, operating expenses, and net loss figures, the overall financial trajectory is negative: total revenue declined year over year and sequentially, and net loss increased by 24%. However, operational improvements such as reduced operating expenses and narrowed loss from operations are highlighted. The narrative inflates the signal by emphasizing 'foundational commercialization', 'pending deployments', and 'potential recurring revenue' from backlogs, but these are not yet realised and are subject to execution risk. The majority of forward-looking claims relate to expected revenue growth and product deployments in the coming quarters, but these are not yet contractually guaranteed or realised. No large capital outlay is disclosed in this quarter, and the company has redirected resources away from a capital-intensive strategy. The gap between narrative and evidence is moderate: operational improvements are real, but the positive tone around future growth is not yet substantiated by realised results.

Risk flags

• ●Liquidity risk is acute: cash and cash equivalents stand at just $94,643, while quarterly net cash used in operations is $2,759,307. Without a near-term capital infusion or a dramatic improvement in cash flow, the company faces a real risk of running out of cash.
• ●Revenue concentration risk is high: revenue from the largest customer fell 59% year over year and now represents only $367,883, down from $894,830. The loss of this customer or further declines could materially impact results.
• ●Dilution risk is significant: the weighted average share count more than doubled to 326 million, indicating heavy reliance on equity issuance to fund operations. This dilutes existing shareholders and may continue if losses persist.
• ●Execution risk on forward-looking claims is substantial: the majority of growth narratives depend on successful deployment and activation of SARA and ROAMEO units, but there is no evidence these will be realized on schedule or at projected revenue levels.
• ●Disclosure risk is present: results are reviewed but unaudited, and there is no full balance sheet, cash flow statement, or granular segment reporting. This limits the ability of investors to fully assess financial health and business drivers.
• ●Profitability risk remains unresolved: despite operational improvements, net loss increased 24% year over year, and the company is not close to break-even. The path to sustained profitability is unclear.
• ●Non-operating cost risk is rising: non-operating costs jumped to $3.0 million from $1.4 million, materially worsening net loss. The nature and recurrence of these costs are not explained.
• ●Forward-looking statement risk is high: over half the claims are aspirational or contingent on future events, such as backlog activation and positive cash flow, which may not materialize as projected.

Bottom line

For investors, this announcement signals a company in transition but still facing severe financial headwinds. While management highlights operational improvements and future growth opportunities, the hard numbers show declining total revenue, widening net losses, and a dangerously low cash balance. The positive narrative around SARA and ROAMEO deployments is not yet backed by realized revenue or binding contracts, and the company’s own disclosures caution that backlog activation and positive cash flow are not assured. The doubling of the share count points to ongoing dilution, and the lack of audited financials or detailed segment data makes it difficult to independently verify management’s claims. No external institutional investors or strategic partners are mentioned, so there is no outside validation of the business model or growth prospects. To change this assessment, the company would need to deliver audited, sustained revenue growth, demonstrate recurring profitability, and secure new capital or strategic partnerships. Key metrics to watch in the next period are realized recurring revenue from SARA and ROAMEO, cash balance, net cash used in operations, and any evidence of new customer wins or contractually guaranteed backlog conversion. At this stage, the announcement is more a signal to monitor than to act on: the risks are high, the upside is speculative, and the most important takeaway is that operational progress has not yet translated into financial stability or investable momentum.

Announcement summary

(OTC:AITX) Artificial Intelligence Technology Solutions, Inc. announced its reviewed but unaudited financial results for the first quarter of fiscal year 2027, reporting revenue for the three months ended May 31, 2026 totaling $1,831,202. Revenue from customers other than the Company's largest customer totaled $1,463,319, representing growth of approximately 52% year over year and approximately 16% sequentially. Gross profit for the quarter was $1,183,824 with a gross margin of approximately 65%, while operating expenses declined to $3,893,188, an approximately 12% reduction from the prior-year period. Loss from operations narrowed to $2,709,364, an improvement of approximately 15%, but net loss increased to $5,715,838, up approximately 24% year over year, primarily due to approximately $3.0 million of non-operating costs. Cash and cash equivalents as of May 31, 2026 totaled $94,643, and net cash used in operating activities declined to $2,759,307, an improvement of approximately 17%. The company projects Q2 FY2027 revenue to exceed Q1 FY2027 revenue by more than 10%, and targets achieving at least one month of positive cash flow from operating activities during calendar 2026.

Disagree with this article?